Clinical Trial Update: A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and immune response of an investigational RSV OA vaccine in combination with a herpes zoster vaccine in healthy adults has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV OA vaccine
• Shingrix (recombinant zoster vaccine) (recombinant zoster vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Syncytial Viruses, Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2025-04-01